Related references
Note: Only part of the references are listed.Nicotine reduces levodopa-induced dyskinesias in lesioned monkeys
Maryka Quik et al.
ANNALS OF NEUROLOGY (2007)
Re-emergence of striatal cholinergic interneurons in movement disorders
Antonio Pisani et al.
TRENDS IN NEUROSCIENCES (2007)
Dopaminergic neurons intrinsic to the striatum
Philippe Huot et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Advances in the treatment of Parkinson's disease
Neha Singh et al.
PROGRESS IN NEUROBIOLOGY (2007)
Dopamine turnover is upregulated in the caudate/putamen of asymptomatic MPTP-treated rhesus monkeys
Christian Pifl et al.
NEUROCHEMISTRY INTERNATIONAL (2006)
Chronic oral nicotine normalizes dopaminergic function and synaptic plasticity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned primates
M Quik et al.
JOURNAL OF NEUROSCIENCE (2006)
Compensation in pre-synaptic dopaminergic function following nigrostriatal damage in primates
SE McCallum et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Neurochemical characterization of the release and uptake of dopamine in ventral tegmental area and serotonin in substantia nigra of the mouse
CE John et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Pathophysiology of motor fluctuations in Parkinson's disease
K Widnell
MOVEMENT DISORDERS (2005)
How does Parkinson's disease begin? The role of compensatory mechanisms
JA Obeso et al.
TRENDS IN NEUROSCIENCES (2004)
Cholinergic drugs for Alzheimer's disease enhance in vitro dopamine release
LF Zhang et al.
MOLECULAR PHARMACOLOGY (2004)
Regulation of dopamine receptor and neuropeptide expression in the basal ganglia of monkeys treated with MPTP
R Betarbet et al.
EXPERIMENTAL NEUROLOGY (2004)
'Passive stabilization' of striatal extracellular dopamine across the lesion spectrum encompassing the presymptomatic phase of Parkinson's disease: a voltammetric study in the 6-OHDA-lesioned rat
BP Bergstrom et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Presymptomatic compensation in Parkinson's disease is not dopamine-mediated
E Bezard et al.
TRENDS IN NEUROSCIENCES (2003)
Cholinergic interneuron characteristics and nicotinic properties in the striatum
FM Zhou et al.
JOURNAL OF NEUROBIOLOGY (2002)
Neurochemistry and electroanalytical probes
KP Troyer et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2002)
The role of nicotinic acetylcholine receptors in the mechanisms of anesthesia
E Tassonyi et al.
BRAIN RESEARCH BULLETIN (2002)
Ketamine and its preservative, benzethonium chloride, both inhibit human recombinant α7 and α4β2 neuronal nicotinic acetylcholine receptors in Xenopus oocytes
KM Coates et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
Chemical neuroanatomy of the basal ganglia - normal and in Parkinson's disease
O Hornykiewicz
JOURNAL OF CHEMICAL NEUROANATOMY (2001)
Upregulation of striatal preproenkephalin gene expression occurs before the appearance of parkinsonian signs in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine monkeys
E Bezard et al.
NEUROBIOLOGY OF DISEASE (2001)
Partial, graded losses of dopamine terminals in the rat caudate-putamen: an animal model for the study of compensatory adaptation in preclinical parkinsonism
BP Bergstrom et al.
JOURNAL OF NEUROSCIENCE METHODS (2001)
Adaptive changes in the nigrostriatal pathway in response to increased 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration in the mouse
E Bezard et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2000)
Intravenous anesthetics differentially modulate ligand-gated ion channels
P Flood et al.
ANESTHESIOLOGY (2000)
Share Paper
